Technical Analysis for INNT - Innovate Biopharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade D 1.19 0.85% 0.01
INNT closed up 0.85 percent on Tuesday, September 17, 2019, on 2.43 times normal volume.

Earnings due: Sep 27

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Up Up
See historical INNT trend table...

Date Alert Name Type % Chg
Pocket Pivot Bullish Swing Setup 0.00%
Calm After Storm Range Contraction 0.00%
Wide Range Bar Range Expansion 0.00%
Upper Bollinger Band Walk Strength 0.00%
Wide Bands Range Expansion 0.00%
Above Upper BB Strength 0.00%
Up 3 Days in a Row Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
Upper Bollinger Band Walk Strength 0.85%
Wide Bands Range Expansion 0.85%

Older signals for INNT ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Innovate Biopharmaceuticals, Inc., formerly Monster Digital, Inc., is a clinical stage biotechnology company. The Company is focused on developing novel autoimmune and inflammation therapeutic drugs. Its lead drug candidate, larazotide acetate (INN-202) is a tight junction regulator. Its other products include INN-108 and INN-329 (Secretin). The Company’s INN-108 is a novel small molecule comprised of two active parts with anti- inflammatory and immunodulatory properties coupled through an azo bond. The Company is developing INN-108 as a therapeutic for Ulcerative Colitis (UC). Its Secretin stimulated magnetic resonance cholangiopancreatography (MRCP) is a ionizing, radiation-free assessment of the pancreaticobiliary system. The Company has completed a phase II b clinical trial for celiac disease for INN-202. It is developing INN-108 in a phase II trial for inflammatory bowel disorders, mild to moderate UC and a Gastrointestinal (GI) orphan disease.
Medicine Biotechnology Biopharmaceutical Medical Specialties Autoimmune Diseases Inflammation Radiation Inflammatory Bowel Disease Ulcerative Colitis Abdominal Pain Diarrhea Digestive Diseases Colitis Celiac Disease Gastrointestinal Tract
Is INNT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 2 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 8.78
52 Week Low 0.728
Average Volume 176,307
200-Day Moving Average 1.6665
50-Day Moving Average 0.98
20-Day Moving Average 0.9477
10-Day Moving Average 1.023
Average True Range 0.087
ADX 35.01
+DI 38.3068
-DI 6.4707
Chandelier Exit (Long, 3 ATRs ) 1.029
Chandelier Exit (Short, 3 ATRs ) 1.011
Upper Bollinger Band 1.1914
Lower Bollinger Band 0.704
Percent B (%b) 1.0
BandWidth 51.429777
MACD Line 0.0546
MACD Signal Line 0.0124
MACD Histogram 0.0422
Fundamentals Value
Market Cap 11.12 Million
Num Shares 9.35 Million
EPS -0.89
Price-to-Earnings (P/E) Ratio -1.33
Price-to-Sales 1.94
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.48
Resistance 3 (R3) 1.48 1.38 1.43
Resistance 2 (R2) 1.38 1.31 1.38 1.41
Resistance 1 (R1) 1.29 1.27 1.34 1.29 1.40
Pivot Point 1.19 1.19 1.22 1.19 1.19
Support 1 (S1) 1.10 1.12 1.15 1.10 0.98
Support 2 (S2) 1.00 1.08 1.00 0.97
Support 3 (S3) 0.91 1.00 0.95
Support 4 (S4) 0.91